Dave A. Ghatt

Array ( [id] => 4004251 [patent_doc_number] => 06004937 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11]' [patent_app_type] => 1 [patent_app_number] => 9/037118 [patent_app_country] => US [patent_app_date] => 1998-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3536 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004937.pdf [firstpage_image] =>[orig_patent_app_number] => 037118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4421594 [patent_doc_number] => 06225300 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'TNF receptor and steroid hormone in a combined therapy' [patent_app_type] => 1 [patent_app_number] => 8/983223 [patent_app_country] => US [patent_app_date] => 1998-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4827 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225300.pdf [firstpage_image] =>[orig_patent_app_number] => 983223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4098984 [patent_doc_number] => 06048846 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Compositions used in human treatment' [patent_app_type] => 1 [patent_app_number] => 9/031227 [patent_app_country] => US [patent_app_date] => 1998-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 8 [patent_no_of_words] => 10875 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048846.pdf [firstpage_image] =>[orig_patent_app_number] => 031227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4153397 [patent_doc_number] => 06124259 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Method for treating ophthalmic disorders with IGFBP' [patent_app_type] => 1 [patent_app_number] => 9/080366 [patent_app_country] => US [patent_app_date] => 1998-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7611 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/124/06124259.pdf [firstpage_image] =>[orig_patent_app_number] => 080366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1461521 [patent_doc_number] => 06350430 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Melanocortin receptor ligands and methods of using same' [patent_app_type] => B1 [patent_app_number] => 09/027108 [patent_app_country] => US [patent_app_date] => 1998-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 8836 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350430.pdf [firstpage_image] =>[orig_patent_app_number] => 09027108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4408647 [patent_doc_number] => 06239111 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'In vivo method of improving survival rate of brain neurons' [patent_app_type] => 1 [patent_app_number] => 8/983322 [patent_app_country] => US [patent_app_date] => 1998-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2466 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239111.pdf [firstpage_image] =>[orig_patent_app_number] => 983322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3986335 [patent_doc_number] => 05985239 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Derivatives of N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters' [patent_app_type] => 1 [patent_app_number] => 9/006861 [patent_app_country] => US [patent_app_date] => 1998-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3927 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985239.pdf [firstpage_image] =>[orig_patent_app_number] => 006861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4247832 [patent_doc_number] => 06136784 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Amylin agonist pharmaceutical compositions containing insulin' [patent_app_type] => 1 [patent_app_number] => 9/005240 [patent_app_country] => US [patent_app_date] => 1998-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 28 [patent_no_of_words] => 22025 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136784.pdf [firstpage_image] =>[orig_patent_app_number] => 005240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3925530 [patent_doc_number] => 05952295 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract' [patent_app_type] => 1 [patent_app_number] => 9/003269 [patent_app_country] => US [patent_app_date] => 1998-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 3933 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952295.pdf [firstpage_image] =>[orig_patent_app_number] => 003269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4103699 [patent_doc_number] => 06051558 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-18 [patent_title] => 'Compositions suitable for controlled release of the hormone GnRH and its analogs' [patent_app_type] => 1 [patent_app_number] => 9/001123 [patent_app_country] => US [patent_app_date] => 1997-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5935 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/051/06051558.pdf [firstpage_image] =>[orig_patent_app_number] => 001123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359940 [patent_doc_number] => 06169071 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => 'Compounds and methods for modulating cell adhesion' [patent_app_type] => 1 [patent_app_number] => 8/996679 [patent_app_country] => US [patent_app_date] => 1997-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 55 [patent_no_of_words] => 33134 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/169/06169071.pdf [firstpage_image] =>[orig_patent_app_number] => 996679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4022610 [patent_doc_number] => 05925619 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Formulation for peptide release' [patent_app_type] => 1 [patent_app_number] => 8/981285 [patent_app_country] => US [patent_app_date] => 1997-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 3100 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925619.pdf [firstpage_image] =>[orig_patent_app_number] => 981285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937083 [patent_doc_number] => 05972895 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Composition and method for increasing growth hormone levels' [patent_app_type] => 1 [patent_app_number] => 8/989160 [patent_app_country] => US [patent_app_date] => 1997-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2322 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972895.pdf [firstpage_image] =>[orig_patent_app_number] => 989160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3983012 [patent_doc_number] => 05958885 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-28 [patent_title] => 'Peptide and formulations thereof inhibiting elevations of triglyceride levels in blood' [patent_app_type] => 1 [patent_app_number] => 8/973539 [patent_app_country] => US [patent_app_date] => 1997-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 5787 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/958/05958885.pdf [firstpage_image] =>[orig_patent_app_number] => 973539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4145008 [patent_doc_number] => 06031073 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Cyclic polypeptides comprising a thioether linkage and methods for their preparation' [patent_app_type] => 1 [patent_app_number] => 8/974297 [patent_app_country] => US [patent_app_date] => 1997-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27599 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/031/06031073.pdf [firstpage_image] =>[orig_patent_app_number] => 974297 [rel_patent_id] =>[rel_patent_doc_number] =>)